Pharmaceuticals
Sanofi unit Genzyme in alliance with Alnylam Pharmaceuticals to develop RNAi therapeutics
13 Jan 2014
Novartis arm faces criminal case in Japan over exaggerated advertising
09 Jan 2014
Under Japanese law, anyone found guilty of exaggerated advertising can be punished with up to two years in prison or a fine of as much as ¥2 million
Forest Labs acquires Aptalis for $2.9 bn
09 Jan 2014
The acquisition of Aptalis will help diversify Forest's pharmaceuticals portfolio while advancing its strategy to create blockbuster therapeutics
Thermo Fischer to sell cell research business to GE for over $1 bn
07 Jan 2014
The world’s second-largest laboratory equipment and supplies provider Thermo Fischer Scientific Inc will sell its cell research business to GE Healthcare for $1.06 billion,to gain EC’s approval for is acquisition of rival Life Technologies
Drug companies in UK not sharing complete information on clinical trials with doctors: MPs
04 Jan 2014
Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada
30 Dec 2013
The drug, which gained approval in the EU in September, and in Australia and Canada this month, formed a key part of Sanofi’s $20.1-billion acquisition of Genzyme in 2011
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 Dec 2013
The acquisition will boost AstraZeneca's presence in the emerging markets, where diabetes is a fast-growing problem and by 2030, is expected to accout of two-thirds of the world's diabetic population
